ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,499 | -22.0% | 3,223 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $25,010 | +108.4% | 3,223 | +37.8% | 0.00% | – |
| Q1 2022 | $12,000 | -64.7% | 2,339 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $34,000 | -30.6% | 2,339 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $49,000 | +48.5% | 2,339 | +25.8% | 0.00% | +100.0% |
| Q2 2021 | $33,000 | -28.3% | 1,859 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $46,000 | -27.0% | 1,859 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $63,000 | +231.6% | 1,859 | +141.7% | 0.00% | +200.0% |
| Q3 2020 | $19,000 | -26.9% | 769 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $26,000 | – | 769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $116,820,000 | 11.19% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $14,756,000 | 9.10% |
| Euclidean Capital LLC | 996,734 | $24,420,000 | 8.17% |
| Invus Financial Advisors, LLC | 1,007,575 | $24,686,000 | 5.66% |
| EcoR1 Capital, LLC | 3,092,218 | $75,759,000 | 3.36% |
| Ally Bridge Group (NY) LLC | 413,061 | $10,120,000 | 1.94% |
| EMERALD ADVISERS, LLC | 615,511 | $15,080,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $57,271,000 | 0.54% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 624,210 | $15,293,000 | 0.51% |
| Casdin Capital, LLC | 601,515 | $14,737,000 | 0.44% |